🇺🇸 FDA
Pipeline program

Plasma rich in growth factors

BTIIMD-01-EC-23-PIED

Approved small_molecule active

Quick answer

Plasma rich in growth factors for Foot ulcers in diabetic patients with peripheral arterial disease is a Approved program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Foot ulcers in diabetic patients with peripheral arterial disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials